Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 4287

1.

Integrating the molecular and the population approaches to dementia research to help guide the future development of appropriate therapeutics.

Hunter S, Brayne C.

Biochem Pharmacol. 2014 Apr 15;88(4):652-60. doi: 10.1016/j.bcp.2013.12.015. Epub 2013 Dec 31. Review.

PMID:
24389044
2.

Ischemia/reperfusion injury: effect of simultaneous inhibition of plasma cascade systems versus specific complement inhibition.

Duehrkop C, Rieben R.

Biochem Pharmacol. 2014 Mar 1;88(1):12-22. doi: 10.1016/j.bcp.2013.12.013. Epub 2013 Dec 30. Review.

PMID:
24384116
3.

Brain metabolic dysfunction at the core of Alzheimer's disease.

de la Monte SM, Tong M.

Biochem Pharmacol. 2014 Apr 15;88(4):548-59. doi: 10.1016/j.bcp.2013.12.012. Epub 2013 Dec 28. Review.

4.

LW-214, a newly synthesized flavonoid, induces intrinsic apoptosis pathway by down-regulating Trx-1 in MCF-7 human breast cells.

Pan D, Li W, Miao H, Yao J, Li Z, Wei L, Zhao L, Guo Q.

Biochem Pharmacol. 2014 Feb 15;87(4):598-610. doi: 10.1016/j.bcp.2013.12.010. Epub 2013 Dec 27.

PMID:
24374359
5.

miR-205 impairs the autophagic flux and enhances cisplatin cytotoxicity in castration-resistant prostate cancer cells.

Pennati M, Lopergolo A, Profumo V, De Cesare M, Sbarra S, Valdagni R, Zaffaroni N, Gandellini P, Folini M.

Biochem Pharmacol. 2014 Feb 15;87(4):579-97. doi: 10.1016/j.bcp.2013.12.009. Epub 2013 Dec 24.

PMID:
24370341
6.

Reduction of thyroid hormones triggers down-regulation of hepatic CYP2B through nuclear receptors CAR and TR in a rat model of acute stroke.

Bing Y, Zhu S, Jiang K, Dong G, Li J, Yang Z, Yang J, Yue J.

Biochem Pharmacol. 2014 Feb 15;87(4):636-49. doi: 10.1016/j.bcp.2013.12.011. Epub 2013 Dec 22.

PMID:
24368200
7.

Tau-aggregation inhibitor therapy for Alzheimer's disease.

Wischik CM, Harrington CR, Storey JM.

Biochem Pharmacol. 2014 Apr 15;88(4):529-39. doi: 10.1016/j.bcp.2013.12.008. Epub 2013 Dec 19. Review.

8.

Common defects of mitochondria and iron in neurodegeneration and diabetes (MIND): a paradigm worth exploring.

Stroh M, Swerdlow RH, Zhu H.

Biochem Pharmacol. 2014 Apr 15;88(4):573-83. doi: 10.1016/j.bcp.2013.11.022. Epub 2013 Dec 19. Review.

9.

PGE2/EP4 signaling in peripheral immune cells promotes development of experimental autoimmune encephalomyelitis.

Schiffmann S, Weigert A, Männich J, Eberle M, Birod K, Häussler A, Ferreiros N, Schreiber Y, Kunkel H, Grez M, Weichand B, Brüne B, Pfeilschifter W, Nüsing R, Niederberger E, Grösch S, Scholich K, Geisslinger G.

Biochem Pharmacol. 2014 Feb 15;87(4):625-35. doi: 10.1016/j.bcp.2013.12.006. Epub 2013 Dec 16.

PMID:
24355567
10.

TREM2 and the neuroimmunology of Alzheimer's disease.

Hickman SE, El Khoury J.

Biochem Pharmacol. 2014 Apr 15;88(4):495-8. doi: 10.1016/j.bcp.2013.11.021. Epub 2013 Dec 16. Review.

11.

Role of metabotropic glutamate receptors in the regulation of pancreatic functions.

Babic T, Travagli RA.

Biochem Pharmacol. 2014 Feb 15;87(4):535-42. doi: 10.1016/j.bcp.2013.12.001. Epub 2013 Dec 16. Review.

12.

(R,R')-4'-methoxy-1-naphthylfenoterol targets GPR55-mediated ligand internalization and impairs cancer cell motility.

Paul RK, Wnorowski A, Gonzalez-Mariscal I, Nayak SK, Pajak K, Moaddel R, Indig FE, Bernier M, Wainer IW.

Biochem Pharmacol. 2014 Feb 15;87(4):547-61. doi: 10.1016/j.bcp.2013.11.020. Epub 2013 Dec 16.

13.

Anti-leprosy drug clofazimine inhibits growth of triple-negative breast cancer cells via inhibition of canonical Wnt signaling.

Koval AV, Vlasov P, Shichkova P, Khunderyakova S, Markov Y, Panchenko J, Volodina A, Kondrashov FA, Katanaev VL.

Biochem Pharmacol. 2014 Feb 15;87(4):571-8. doi: 10.1016/j.bcp.2013.12.007. Epub 2013 Dec 16.

PMID:
24355563
14.

CYP2E1 hydroxylation of aniline involves negative cooperativity.

Hartman JH, Knott K, Miller GP.

Biochem Pharmacol. 2014 Feb 1;87(3):523-33. doi: 10.1016/j.bcp.2013.12.003. Epub 2013 Dec 15.

PMID:
24345333
15.

Regulation of autophagy by miR-30d impacts sensitivity of anaplastic thyroid carcinoma to cisplatin.

Zhang Y, Yang WQ, Zhu H, Qian YY, Zhou L, Ren YJ, Ren XC, Zhang L, Liu XP, Liu CG, Ming ZJ, Li B, Chen B, Wang JR, Liu YB, Yang JM.

Biochem Pharmacol. 2014 Feb 15;87(4):562-70. doi: 10.1016/j.bcp.2013.12.004. Epub 2013 Dec 15.

16.

Cap-dependent translation initiation factor, eIF4E, is the target for Ouabain-mediated inhibition of HIF-1α.

Cao J, He L, Lin G, Hu C, Dong R, Zhang J, Zhu H, Hu Y, Wagner CR, He Q, Yang B.

Biochem Pharmacol. 2014 May 1;89(1):20-30. doi: 10.1016/j.bcp.2013.12.002. Epub 2013 Dec 15.

PMID:
24345331
17.

Aspirin attenuates vinorelbine-induced endothelial inflammation via modulating SIRT1/AMPK axis.

Tsai KL, Huang PH, Kao CL, Leu HB, Cheng YH, Liao YW, Yang YP, Chien Y, Wang CY, Hsiao CY, Chiou SH, Chen JW, Lin SJ.

Biochem Pharmacol. 2014 Mar 15;88(2):189-200. doi: 10.1016/j.bcp.2013.12.005. Epub 2013 Dec 15.

PMID:
24345330
18.

2-Methoxystypandrone ameliorates brain function through preserving BBB integrity and promoting neurogenesis in mice with acute ischemic stroke.

Chern CM, Wang YH, Liou KT, Hou YC, Chen CC, Shen YC.

Biochem Pharmacol. 2014 Feb 1;87(3):502-14. doi: 10.1016/j.bcp.2013.11.018. Epub 2013 Dec 14.

PMID:
24342702
19.

Mitochondrial respiration as a target for neuroprotection and cognitive enhancement.

Gonzalez-Lima F, Barksdale BR, Rojas JC.

Biochem Pharmacol. 2014 Apr 15;88(4):584-93. doi: 10.1016/j.bcp.2013.11.010. Epub 2013 Dec 4. Review.

PMID:
24316434
20.

A designed equine herpes thymidine kinase (EHV4 TK) variant improves ganciclovir-induced cell-killing.

McSorley T, Ort S, Monnerjahn C, Konrad M.

Biochem Pharmacol. 2014 Feb 1;87(3):435-44. doi: 10.1016/j.bcp.2013.11.011. Epub 2013 Dec 4.

PMID:
24316433

Supplemental Content

Loading ...
Support Center